Q1 2024 · 13F-HR
MFN Partners Management, LPholdings as filed
Filed 2024-05-10 · accession 0000904454-24-000283
$3.52B
Reported value
10
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 983793100 | XPO | XPO INC | $1.55B | 43.9% | 12,675,369 | Common | SOLE |
| 536797103 | LAD | LITHIA MTRS INC | $466.7M | 13.2% | 1,551,077 | Common | SOLE |
| 70932M107 | PFSI | PENNYMAC FINL SVCS INC NEW | $412.8M | 11.7% | 4,531,792 | Common | SOLE |
| 74982T103 | RXO | RXO INC | $340.9M | 9.68% | 15,588,555 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $324.8M | 9.22% | 973,898 | Common | SOLE |
| 674599162 | OXY/WS | OCCIDENTAL PETE CORP | $245.3M | 6.96% | 5,690,600 | Common | SOLE |
| G61188127 | LBTYK | LIBERTY GLOBAL LTD | $97.0M | 2.75% | 5,499,107 | Common | SOLE |
| 071734107 | BHC | BAUSCH HEALTH COS INC | $63.7M | 1.81% | 6,000,000 | Common | SOLE |
| 46578C108 | IE | IVANHOE ELECTRIC INC | $25.0M | 0.71% | 2,553,191 | Common | SOLE |
| 23255M204 | CYCN | CYCLERION THERAPEUTICS INC | $542,272 | 0.02% | 169,460 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.